Neuro-oncologic Emergencies.
Suarez-Meade P, Marenco-Hillembrand L, Sherman WJ.
Curr Oncol Rep. 2022 Aug;24(8):975-984. doi: 10.1007/s11912-022-01259-3. Epub 2022 Mar 30.
Primary intracranial epithelioid hemangioendothelioma: a low-proliferation tumor exhibiting clinically malignant behavior.
Zheng J, Liu L, Wang J, Wang S, Cao Y, Zhao J.
J Neurooncol. 2012 Oct;110(1):119-27. doi: 10.1007/s11060-012-0945-x. Epub 2012 Aug 11.
Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy.
Wen J, Liu D, Zhu H, Shu K.
J Neuroinflammation. 2024 Sep 16;21(1):226. doi: 10.1186/s12974-024-03222-4.
Disturbed meningeal lymphatic function associated with malignancy and progression in patients with intracranial malignant tumors.
Wang M, Ran L, Liu B, Wei W, Zhu J, Long F, Song X, Zhang J, Zhao Y, Hu G, Yuan X, Wang W.
Med. 2023 Dec 8;4(12):898-912.e4. doi: 10.1016/j.medj.2023.10.001. Epub 2023 Nov 8.
[Intracranial tumor].
Conter C, Frappaz D.
Rev Prat. 2008 Mar 15;58(5):565-70.
Malignant Intracranial High Grade Glioma and Current Treatment Strategy.
Zhang X, Zhang W, Mao XG, Cao WD, Zhen HN, Hu SJ.
Curr Cancer Drug Targets. 2019;19(2):101-108. doi: 10.2174/1568009618666180530090922.
Targeted next-generation sequencing of malignant peripheral nerve sheath tumor of the pterygopalatine fossa with intracranial metastatic recurrence.
Bao X, Kong X, Yang C, Wu H, Ma W, Wang R.
Medicine (Baltimore). 2018 Jan;97(4):e9636. doi: 10.1097/MD.0000000000009636.
Glioblastoma Biology, Genetics and Possible Therapies.
Castresana JS, Meléndez B.
Cells. 2023 Aug 14;12(16):2063. doi: 10.3390/cells12162063.
Cellular immunotherapy for medulloblastoma.
Schakelaar MY, Monnikhof M, Crnko S, Pijnappel EW, Meeldijk J, Ten Broeke T, Bovenschen N.
Neuro Oncol. 2023 Apr 6;25(4):617-627. doi: 10.1093/neuonc/noac236.
The use of ultrasound in intracranial tumor surgery.
Bal J, Camp SJ, Nandi D.
Acta Neurochir (Wien). 2016 Jun;158(6):1179-85. doi: 10.1007/s00701-016-2803-7. Epub 2016 Apr 22.
